BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 17, Issue 11
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study
©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 112981
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.112981
Table 2 Evaluation of efficacy, n (%)
Parameter
Over best responseCR1 (0.5)
PR32 (16.0)
SD59 (29.5)
PD108 (54.0)
ORRCR + PR33 (16.5)
DCRCR + PR + SD92 (46.0)
CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progression disease; ORR: Objective responds rates; DCR: Disease control rates.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.